Calendar HBM Holdings Limited

Equities

Market Closed - Hong Kong S.E. Other stock markets 09:08:22 29/04/2024 BST			5-day change	1st Jan Change
1.24 ^HKD	-0.80%		+14.81%	-36.08%

04-02	HBM Holdings Returns to Profitability in 2023	MT
03-28	HBM Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

67e8f89c8a30.q8AnmPcC0eNPfqVoIkbFommKcyiLFuFOa_UvORgXKDs.8aJX75pDmK0gN-E7ayyv-Fn4BnfYe5YMOdhHXy9AQl-din_5ozWJhwYmnQ~ae5ae5e2d13f855cc230afe8b36af8a9

26/08/2024	Q2 2024 Earnings Release (Projected)
25/03/2025	Q4 2024 Earnings Release (Projected)
01/09/2025	Q2 2025 Earnings Release (Projected)
31/03/2026	Q4 2025 Earnings Release (Projected)

28/03/2024 14:10	Q4 2023 Earnings Release
27/03/2024	Q4 2023 Earnings Call
28/08/2023 05:24	Q2 2023 Earnings Release
22/08/2023	Q2 2023 Earnings Call
08/06/2023 03:00	Annual General Meeting
13/04/2023	American Association for Cancer Research Meeting - Abstract Number: CT263
28/03/2023	Q4 2022 Earnings Release
15/11/2022 12:20	Protein and Antibody Engineering Summit
09/11/2022	Society for Immunotherapy of Cancer Meeting - Abstract No: 477
09/11/2022	Society for Immunotherapy of Cancer Meeting - Abstract No: 858
09/11/2022	Society for Immunotherapy of Cancer Meeting - Abstract No: 1057
09/11/2022	Society for Immunotherapy of Cancer Meeting - Abstract No: 1075
09/11/2022	Society for Immunotherapy of Cancer Meeting - Abstract No: 1361
31/08/2022 14:30	Interim 2022 Earnings Call
30/08/2022	Interim 2022 Earnings Release
02/06/2022	American Society of Clinical Oncology Meeting - Abstract number: 363712
02/06/2022	American Society of Clinical Oncology Meeting - Abstract number: 368316
07/04/2022	American Association of Cancer Research Meeting - Abstract Number: 4398
23/03/2022	FY 2021 Earnings Call
23/03/2022	FY 2021 Earnings Release

Fiscal Period	December	2020	2021	2022
Net sales Million USD	Released Forecast Spread	14,1 9,19 53.51%	4,31 8,73 -50.68%	40,7 45,1 -9.9%
EBITDA Million USD	Released Forecast Spread	-83,5 -59,2 -40.96%	-138 -126 -9.47%	-116 -133 12.71%
EBIT Million USD	Released Forecast Spread	-87,9 -63,2 -39.15%	-143 -103 -39.46%	-122 -138 11.97%
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-297 -315 5.68%	-138 -130 -6.02%	-137 -124 -10.28%
Net income Million USD	Released Forecast Spread	-296 -226 -31.3%	-138 -75,7 -82%	-137 -123 -11.37%
EPS USD	Released Forecast Spread	-1,69 -0,63 -170.14%	-0,19 -0,12 -54.95%	-0,19 -0,16 -19.14%
Announcement Date		29/03/21	24/03/22	29/03/23

29/04/2024	SHANGHAI RAAS BLOOD PRODUCTS CO., LTD.: Q1 2024 Earnings Release
29/04/2024	SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q4 2023 Earnings Release
29/04/2024	SHANDONG SINOBIOWAY BIOMEDICINE CO., LTD.: Q1 2024 Earnings Release
29/04/2024	BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: Q4 2023 Earnings Release
30/04/2024 12:00	INCYTE CORPORATION: Q1 2024 Earnings Release
01/05/2024	BRIDGEBIO PHARMA, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024	TWIST BIOSCIENCE CORPORATION: Q2 2024 Earnings Release
01/05/2024	SK BIOSCIENCE CO.,LTD.: Q1 2024 Earnings Release
06/05/2024 12:00	AXSOME THERAPEUTICS, INC.: Q1 2024 Earnings Release
06/05/2024	BIOTEST AG: Q1 2024 Earnings Release

Today	HEBEI CHANGSHAN BIOCHEMICAL PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
Today	SHANGHAI OPM BIOSCIENCES CO., LTD.: Q4 2023 Earnings Release
Today	CANSINO BIOLOGICS INC.: Q1 2024 Earnings Release
Today	SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q1 2024 Earnings Release
Today	SINOVAC BIOTECH LTD.: Q4 2023 Earnings Release (Projected)
26/04/2024	PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q4 2023 Earnings Release
26/04/2024	BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.: Q1 2024 Earnings Release
26/04/2024	SHENZHEN KANGTAI BIOLOGICAL PRODUCTS CO., LTD.: Q1 2024 Earnings Release
26/04/2024	PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD: Q1 2024 Earnings Release
26/04/2024	TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release